Cargando…

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways

Since BRCA1 associated breast cancers are frequently classified as hormone receptor negative or even triple negative, the application of endocrine therapies is rather limited in these patients. Like hormone receptors that bind to estrogen or progesterone, thyroid hormone receptors (TRs) are members...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heublein, Sabine, Mayr, Doris, Meindl, Alfons, Angele, Martin, Gallwas, Julia, Jeschke, Udo, Ditsch, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451081/ https://www.ncbi.nlm.nih.gov/pubmed/26029931 http://dx.doi.org/10.1371/journal.pone.0127072

Ejemplares similares

Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis
por: Heublein, Sabine, et al.
Publicado: (2017)

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients
por: Heublein, Sabine, et al.
Publicado: (2015)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
por: Lenhard, Miriam, et al.
Publicado: (2012)

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
por: Lenhard, Miriam, et al.
Publicado: (2013)

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
por: Heublein, Sabine, et al.
Publicado: (2013)

Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer
por: Shao, Wanting, et al.
Publicado: (2020)

Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
por: Scholz, Christoph, et al.
Publicado: (2012)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

The G-Protein Coupled Estrogen Receptor (GPER/GPR30) is a Gonadotropin Receptor Dependent Positive Prognosticator in Ovarian Carcinoma Patients
por: Heublein, Sabine, et al.
Publicado: (2013)

Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
por: Schneider, Mariella, et al.
Publicado: (2023)

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
por: Shao, Wanting, et al.
Publicado: (2021)

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors
por: Heublein, Sabine, et al.
Publicado: (2014)

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers
por: Shao, Wanting, et al.
Publicado: (2020)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023)

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
por: Lenhard, Miriam, et al.
Publicado: (2012)

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
por: Heublein, Sabine, et al.
Publicado: (2013)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of G(i)- Protein- Coupled Receptors
por: Tremmel, Eileen, et al.
Publicado: (2020)

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
por: Rhiem, Kerstin, et al.
Publicado: (2012)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
por: Semmlinger, Anna, et al.
Publicado: (2018)

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
por: Badmann, Susann, et al.
Publicado: (2020)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival()
por: Sixou, Sophie, et al.
Publicado: (2018)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

Expression of H3K4me3 and H3K9ac in breast cancer
por: Berger, Luisa, et al.
Publicado: (2020)

The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer
por: Zehni, Alaleh Zati, et al.
Publicado: (2021)

Prognostic Relevance of RIP140 and ERβ Expression in Unifocal Versus Multifocal Breast Cancers: A Preliminary Report
por: Müller, Katharina, et al.
Publicado: (2019)

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
por: Jeschke, Udo, et al.
Publicado: (2019)

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
por: Lin, Lili, et al.
Publicado: (2021)

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
por: Engelstaedter, Verena, et al.
Publicado: (2012)

Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality
por: Zati zehni, Alaleh, et al.
Publicado: (2019)

First Evidence for a Role of Siglec-8 in Breast Cancer
por: Trebo, Anna, et al.
Publicado: (2021)

KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro
por: Lin, Lili, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8q93np13lddpho5jklblp7663q